M

Mayinglong Pharmaceutical Group Co Ltd
SSE:600993

Watchlist Manager
Mayinglong Pharmaceutical Group Co Ltd
SSE:600993
Watchlist
Price: 25.03 CNY -1.8% Market Closed
Market Cap: 10.8B CNY
Have any thoughts about
Mayinglong Pharmaceutical Group Co Ltd?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

15.5
Current
16.8
Median
13.3
Industry
Lower than median
Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
15.5
=
Enterprise Value
8.2B CNY
/
EBITDA
526.9m CNY
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
12.3
2-Years Forward
EV/EBITDA
10.5
3-Years Forward
EV/EBITDA
9.1

See Also

Discover More